[MAYBANK] QoQ TTM Result on 30-Sep-2016 [#3]

Announcement Date
24-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- -1.68%
YoY- -15.19%
View:
Show?
TTM Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 44,734,460 44,753,568 44,657,902 44,464,550 44,559,857 42,554,416 40,556,371 6.76%
PBT 9,822,677 9,162,175 8,844,450 8,347,548 8,274,386 8,840,880 9,151,548 4.83%
Tax -2,039,657 -1,904,080 -1,880,558 -2,106,398 -1,971,165 -2,115,600 -2,165,160 -3.90%
NP 7,783,020 7,258,095 6,963,892 6,241,150 6,303,221 6,725,280 6,986,388 7.47%
-
NP to SH 7,517,537 7,019,038 6,742,992 6,034,476 6,137,712 6,562,305 6,835,939 6.54%
-
Tax Rate 20.76% 20.78% 21.26% 25.23% 23.82% 23.93% 23.66% -
Total Cost 36,951,440 37,495,473 37,694,010 38,223,400 38,256,636 35,829,136 33,569,983 6.61%
-
Net Worth 69,758,780 70,457,936 68,422,732 65,606,580 62,312,149 61,977,906 61,131,868 9.20%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 5,632,502 5,225,070 5,225,070 4,869,452 4,869,452 5,170,805 5,170,805 5.87%
Div Payout % 74.92% 74.44% 77.49% 80.69% 79.34% 78.80% 75.64% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 69,758,780 70,457,936 68,422,732 65,606,580 62,312,149 61,977,906 61,131,868 9.20%
NOSH 10,326,525 10,178,105 10,179,378 9,992,777 9,838,346 9,745,566 9,672,611 4.46%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 17.40% 16.22% 15.59% 14.04% 14.15% 15.80% 17.23% -
ROE 10.78% 9.96% 9.85% 9.20% 9.85% 10.59% 11.18% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 433.20 439.70 438.71 444.97 452.92 436.65 419.29 2.20%
EPS 72.80 68.96 66.24 60.39 62.39 67.34 70.67 2.00%
DPS 54.54 51.34 51.33 48.73 49.49 53.06 53.46 1.34%
NAPS 6.7553 6.9225 6.7217 6.5654 6.3336 6.3596 6.3201 4.54%
Adjusted Per Share Value based on latest NOSH - 9,992,777
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 370.72 370.88 370.08 368.48 369.27 352.65 336.09 6.76%
EPS 62.30 58.17 55.88 50.01 50.86 54.38 56.65 6.54%
DPS 46.68 43.30 43.30 40.35 40.35 42.85 42.85 5.87%
NAPS 5.781 5.8389 5.6703 5.4369 5.1639 5.1362 5.0661 9.20%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 9.63 8.92 8.20 7.50 8.14 9.02 8.40 -
P/RPS 2.22 2.03 1.87 1.69 1.80 2.07 2.00 7.21%
P/EPS 13.23 12.93 12.38 12.42 13.05 13.40 11.89 7.38%
EY 7.56 7.73 8.08 8.05 7.66 7.47 8.41 -6.86%
DY 5.66 5.76 6.26 6.50 6.08 5.88 6.36 -7.48%
P/NAPS 1.43 1.29 1.22 1.14 1.29 1.42 1.33 4.95%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/08/17 25/05/17 23/02/17 24/11/16 25/08/16 27/05/16 25/02/16 -
Price 9.46 9.39 8.40 7.70 7.90 8.27 8.64 -
P/RPS 2.18 2.14 1.91 1.73 1.74 1.89 2.06 3.85%
P/EPS 12.99 13.62 12.68 12.75 12.66 12.28 12.23 4.10%
EY 7.70 7.34 7.89 7.84 7.90 8.14 8.18 -3.95%
DY 5.77 5.47 6.11 6.33 6.27 6.42 6.19 -4.58%
P/NAPS 1.40 1.36 1.25 1.17 1.25 1.30 1.37 1.45%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment